Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015–2016

  • Fang XuEmail author
  • James M. Dahlhamer
  • Emily P. Terlizzi
  • Anne G. Wheaton
  • Janet B. Croft
Original Article



Previous reports suggest that adults with inflammatory bowel disease (IBD) receive suboptimal preventive care.


The population-based study compared the receipt of these services by US adults with and without IBD.


Adults aged ≥ 18 years with IBD (1.2%) and without IBD were identified from the 2015 and 2016 National Health Interview Survey (n = 66,610). Age-standardized prevalence of doctor visits, receipt of medical advice, and selected preventive care was calculated for adults with and without IBD. The model-adjusted prevalence ratios were estimated for receipt of preventive care associated with IBD.


The prevalence of a doctor visit in the past 12 months was significantly higher among adults with IBD than those without. IBD was also associated with significantly higher prevalence of receiving medical advice about smoking cessation (83.9% vs. 66.4%) and diet (42.9% vs. 32.1%), having colon cancer screening in the past 12 months (44.0% vs. 26.7%), having ever had an HIV test (51.5% vs. 45.4%) or pneumococcal vaccine (75.3% vs. 64.0%), having received a tetanus vaccine in the past 10 years (72.0% vs. 61.8%), and having received a flu vaccine in the past 12 months (48.4% vs. 41.0%), but was not significantly associated with receiving cervical cancer screening and hepatitis A and B vaccines.


Adults with IBD were more likely to receive many types of preventive care than adults without IBD. The findings can inform healthcare policy makers to make strategic decisions that enhance multidisciplinary coordination from various medical specialties to ensure optimal preventive care for IBD patients.


Inflammatory bowel disease Crohn’s disease Ulcerative colitis Preventive care services 



The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Author’s contribution

FX drafted the paper. JMD and EPT conducted data analyses. FX, JMD, EPT, AGW, and JBC participated in the study design, interpreted the results, reviewed and edited the paper, and approved the final version.

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to disclose.


  1. 1.
    Xu F, Dahlhamer JM, Zammitti EP, Wheaton AG, Croft JB. Health-risk behaviors and chronic conditions among adults with inflammatory bowel disease—United States, 2015 and 2016. MMWR Morb Mortal Wkly Rep. 2018;67:190–195. Scholar
  2. 2.
    Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn’s Colitis. 2007;1:10–20. Scholar
  3. 3.
    Roman AL, Munoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol. 2011;17:2723–2731. Scholar
  4. 4.
    Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:47–52.CrossRefGoogle Scholar
  5. 5.
    Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Reps. 2008;10:597–605.CrossRefGoogle Scholar
  6. 6.
    Murthy SK, Nguyen GC. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol. 2011;106:713–718.CrossRefGoogle Scholar
  7. 7.
    Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D. Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons. World J Gastroenterol. 2015;21:9688–9692. Scholar
  8. 8.
    Chang M, Chang L, Chang HM, Chang F. Intestinal and extraintestinal cancers associated with inflammatory bowel disease. Clin Colorectal Cancer. 2018;17:e29–e37. Scholar
  9. 9.
    Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn Colitis. 2014;8:443–468. Scholar
  10. 10.
    Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol. 2016;22:7625–7644. Scholar
  11. 11.
    Kremers HM, Bidaut-Russell M, Scott CG, Reinalda MS, Zinsmeister AR, Gabriel SE. Preventive medical services among patients with rheumatoid arthritis. J Rheumatol. 2003;30:1940–1947.Google Scholar
  12. 12.
    Owens MD, Beckles GL, Ho KK, Gorrell P, Brady J, Kaftarian JS. Women with diagnosed diabetes across the life stages: underuse of recommended preventive care services. J Women Health (Larchmt). 2008;17:1415–1423. Scholar
  13. 13.
    Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Ggastroenterol. 2017;112:241–258. Scholar
  14. 14.
    Selby L, Hoellein A, Wilson JF. Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients? Dig Dis Sci. 2011;56:819–824. Scholar
  15. 15.
    National Center for Health Statistics. Survey Description, National Health Interview Survey. 2015. Hyattsville, Maryland. 2016. Avaiable at: Accessed July 13, 2018.
  16. 16.
    National Center for Health Statistics. Survey Description, National Health Interview Survey. 2016. Hyattsville, Maryland. 2017. Avaiable at: Accessed July 13, 2018.
  17. 17.
    U.S. Preventive Service Task Force. U.S. Preventive Service Task Force published recommendations. 2017. Accessed February 27, 2018.
  18. 18.
    Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171:618–623. Scholar
  19. 19.
    National Center for Health Statistics. National Center for Health Statistics data presentation standards for proportions. 2017; Available from Accessed Feburary 23, 2018.
  20. 20.
    Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14:253–258. Scholar
  21. 21.
    Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:62–68. Scholar
  22. 22.
    Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. ScientificWorldJournal. 2015;2015:438402. Scholar
  23. 23.
    Severs M, Mangen MJ, van der Valk ME, et al. Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohn’s Colitis. 2017;11:342–352. Scholar
  24. 24.
    Crohn’s & Colitis Foundation. Nutrition, diet, and inflammatory bowel disease. 2013; Available from: Accessed October 25, 2018.
  25. 25.
    Halmos EP, Gibson PR. Dietary management of IBD–insights and advice. Nat Rev. Gastroenterol Hepatol. 2015;12:133–146. Scholar
  26. 26.
    Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22:4794–4801. Scholar
  27. 27.
    Waszczuk E, Waszczuk K, Bohdanowicz-Pawlak A, Florjanski J. Women with inflammatory bowel diseases have a suboptimal cervical cancer screening rate and are not aware of the recommended human papilloma virus vaccine. Gynecol endocrinol. 2018;34:656–658. Scholar
  28. 28.
    Centers for Disease Control and Prevention. The Advisory Committee on Immunization Practices. 2018; Avaiable at: Accessed July 16, 2018.
  29. 29.
    Gurvits GE, Lan G, Tan A, Weissman A. Vaccination practices in patients with inflammatory bowel disease among general internal medicine physicians in the USA. Postgrad Med J. 2017;93:333–337. Scholar
  30. 30.
    Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis. 2014;20:246–250. Scholar
  31. 31.
    Malhi G, Rumman A, Thanabalan R, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohn’s Colitis. 2015;9:439–444. Scholar

Copyright information

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019

Authors and Affiliations

  • Fang Xu
    • 1
    Email author
  • James M. Dahlhamer
    • 2
  • Emily P. Terlizzi
    • 2
  • Anne G. Wheaton
    • 1
  • Janet B. Croft
    • 1
  1. 1.Division of Population Health, National Center for Chronic Disease Prevention and Health PromotionCenters for Disease Control and PreventionAtlantaUSA
  2. 2.Division of Health Interview Statistics, National Center for Health StatisticsCenters for Disease Control and PreventionHyattsvilleUSA

Personalised recommendations